Get the Stockscreener App
1.70
0.00%
0.00
After Hours:
1.71
0.01
+0.59%
Seer Inc stock is traded at $1.70, with a volume of 61,819.
It is up +0.00% in the last 24 hours and down -1.73% over the past month.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
See More
Previous Close:
$1.70
Open:
$1.68
24h Volume:
61,819
Relative Volume:
0.24
Market Cap:
$95.92M
Revenue:
$16.45M
Net Income/Loss:
$-73.60M
P/E Ratio:
-1.3286
EPS:
-1.2795
Net Cash Flow:
$-46.25M
1W Performance:
+0.59%
1M Performance:
-1.73%
6M Performance:
-23.08%
1Y Performance:
+0.59%
1-Day Range:
$1.67
$1.712
1-Week Range:
$1.65
$1.712
52-Week Range:
$1.62
$2.41
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ARGX, ALNY, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.70 | 95.92M | 16.45M | -73.60M | -46.25M | -1.2795 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Whale Trades: Can Seer Inc deliver consistent EPS growth2026 Patterns & Weekly Consistent Profit Watchlists - baoquankhu1.vn
BRKR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Fundamentals Check: Is now the right time to enter Seer Inc2026 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Bruker, Seer Each Claim Partial Win in US Patent Board Ruling - 富途牛牛
Seer, Inc. (NASDAQ:SEER) Sees Large Decline in Short Interest - MarketBeat
Seer retains patent claims in USPTO review of protein analysis tech - Investing.com Australia
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries - Investing News Network
Seer Strengthens Proteograph IP Following Favorable Patent Ruling - tipranks.com
PTAB upholds key Seer (Nasdaq: SEER) Proteograph patent claims - Stock Titan
Nasdaq Moves: Whats next for Seer Inc stockAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Patent fight ends with Seer keeping 23 claims tied to its protein platform - Stock Titan
Bullish Seer Insiders Loaded Up On US$5.29m Of Stock - Yahoo Finance
Risk Recap: Will Seer Inc outperform the market in YEAR2026 Sector Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Analyst Downgrade: Does Seer Inc meet Warren Buffetts criteriaTake Profit & Real-Time Buy Signal Notifications - baoquankhu1.vn
US Market Wrap: Should you avoid Seer Inc stock right now2026 Big Picture & Real-Time Volume Analysis Alerts - baoquankhu1.vn
TD Cowen Maintains Seer Inc(SEER.US) With Buy Rating - 富途牛牛
Seer (NASDAQ:SEER) Shares Down 2.6%Here's What Happened - MarketBeat
SEER Should I Buy - Intellectia AI
SEER.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SEER.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SEER News & Events - Intellectia AI
SEER.O Technical Analysis & Stock Price Forecast - Intellectia AI
Retail Trends: What is the target price for Seer Inc stockProduct Launch & Daily Oversold Bounce Ideas - baoquankhu1.vn
Seer Inc stock (ISIN: US8158581079) gains traction as protein-analysis platform expands clinical ado - AD HOC NEWS
Seer, Inc. Announces Amendment No. 1 to Tax Benefit Preservation Plan in Latest 8-K Filing - Minichart
Seer amends tax benefit plan and agrees to $250,000 mootness fee in stockholder suit By Investing.com - Investing.com India
Seer amends tax benefit plan and agrees to $250,000 mootness fee in stockholder suit - Investing.com Nigeria
Seer Amends Tax Benefit Plan After Stockholder Challenge - TipRanks
Seer (NASDAQ: SEER) updates tax benefit plan after Delaware action - Stock Titan
Aug PostEarnings: Will Seer Inc stock recover after earningsTrade Exit Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
Setup Watch: What is the target price for Seer Inc stock2025 Market WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
Aug Sectors: Is now the right time to enter Seer IncWeekly Gains Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
Sentiment Watch: Whats the fair value of AEV CL stockAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Sectors Review: Can Seer Inc be recession proof2025 Price Momentum & Weekly High Momentum Picks - baoquankhu1.vn
Aug Volume: What is the target price for Seer Inc stockEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
SEER: Strong growth, innovation, and new detector tech set the stage for future expansion - TradingView
Bradley Radoff Sends Open Letter to Seer, Inc. - marketscreener.com
Seer (SEER) Stockholders Express Concerns Over Management and Fi - GuruFocus
Incorrect alert on Seer Inc's forecast withdrawn - marketscreener.com
Radoff-Jec Group calls on Seer board to announce sale process - marketscreener.com
The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs - Stock Titan
SEER Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Activist group in Seer (SEER) reports 7.6% stake and opposes NOL pill - Stock Titan
Seer (NASDAQ: SEER) expands Proteograph platform and targets $30B proteomics market - Stock Titan
Seer 10-K: Revenue $16.58M, EPS $(1.28) - TradingView
Tranche Update on Seer, Inc.'s Equity Buyback Plan announced on May 8, 2024. - MarketScreener
Seer Inc. Balances Growth Momentum With Cautious Outlook - TipRanks
Seer, Inc. (NASDAQ:SEER) Q4 2025 Earnings Call Transcript - Insider Monkey
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Seer Q4 Earnings Call Highlights - Yahoo Finance
Seer, Inc. (NASDAQ:SEER) Short Interest Up 126.6% in February - MarketBeat
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):